Harmony Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Sell
8,341
-493
-6% -$115K 0.57% 48
2026
Q1
$2.16M Buy
8,834
+496
+6% +$116K 0.66% 42
2025
Q4
$1.73M Buy
8,338
+24
+0.3% +$4.75K 0.58% 41
2025
Q3
$1.54M Sell
8,314
-584
-7% -$100K 0.53% 51
2025
Q2
$1.36M Sell
8,898
-956
-10% -$147K 0.51% 58
2025
Q1
$1.63M Sell
9,854
-5,206
-35% -$815K 0.69% 40
2024
Q4
$2.18M Sell
15,060
-4,727
-24% -$733K 0.86% 34
2024
Q3
$3.21M Buy
19,787
+576
+3% +$91.8K 1.18% 24
2024
Q2
$2.81M Buy
19,211
+3,490
+22% +$519K 1.18% 26
2024
Q1
$2.49M Sell
15,721
-679
-4% -$108K 1.03% 31
2023
Q4
$2.57M Buy
+16,400
New +$2.51M 1.09% 30

Other funds holding JNJ

Harmony Asset Management's JNJ Position: Q2 2026 in Review

Harmony Asset Management reduced its Johnson & Johnson (JNJ) stake by 5.6% in Q2 2026, selling an estimated $115K and leaving 8,341 shares worth $2.12M. The position accounts for 0.57% of the portfolio, ranked #48.

Harmony Asset Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.21M in Q3 2024. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Harmony Asset Management held 8,341 shares of Johnson & Johnson worth $2.12M as of Q2 2026.
  • Harmony Asset Management sold 493 Johnson & Johnson shares in Q2 2026, an estimated $115K.
  • Johnson & Johnson made up 0.57% of Harmony Asset Management's portfolio in Q2 2026, its #48 holding.
  • Harmony Asset Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Harmony Asset Management's Johnson & Johnson position peaked at $3.21M in Q3 2024.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Harmony Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.